← Leaderboards
Qizhi Tang
University Of California San Francisco
$8,696,514
Attributed
$18,046,880
Total exposure
13
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.2M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$18,046,880 · 13
By mechanism
U01$7,681,808 · 2
R01$4,439,893 · 2
U24$1,967,535 · 1
P30$1,544,712 · 3
UG3$1,108,154 · 1
S10$495,100 · 1
Top collaborators
- Michael T Mcmanus9 shared
- Jeffrey A Bluestone7 shared
- Sandy Feng7 shared
- Sang-Mo Kang7 shared
- Gregory Michael Ku5 shared
- Zoltan Laszik5 shared
- Audrey Parent4 shared
- David N. Ikle2 shared
Most similar at University Of California San Francisco
Same institution · by research overlap
- Sang-Mo Kang$2,017,044
- Neetu Gupta$6,410,156
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsTissuesBaseMediatingImmuneTransplantationInflammationInsulin-Dependent Diabetes MellitusTechnologyDesignImmune ResponseMouse ModelImmune SystemImmunologicsMolecularInflammatoryIn VivoOrganIsletPreventMaintenanceEnsureDiabetes MellitusLaboratories
Grant awards (39)
Stem cell-based modeling of type 1 diabetes to accelerate translation of therapies$1,108,154
UG3 · FY2025 · DK
iSTAR Tregs$968,716
U01 · FY2025 · DK · contact PI
Genome editing of human pancreatic islets to withstand ischemic injuries and promote immune evasion$686,375
R01 · FY2025 · DK · contact PI
Core B: Flow and Mass Cytometry$367,092
P30 · FY2025 · DK · contact PI
Genome editing of human pancreatic islets to withstand ischemic injuries and promote immune evasion$24,815
R01 · FY2025 · DK · contact PI
iSTAR Tregs$968,858
U01 · FY2024 · DK · contact PI
Genome editing of human pancreatic islets to withstand ischemic injuries and promote immune evasion$658,920
R01 · FY2024 · DK · contact PI
Genome editing of human pancreatic islets to withstand ischemic injuries and promote immune evasion$74,445
R01 · FY2024 · DK · contact PI
iSTAR Tregs$969,000
U01 · FY2023 · DK · contact PI
Genome editing of human pancreatic islets to withstand ischemic injuries and promote immune evasion$686,375
R01 · FY2023 · DK · contact PI
Genome editing of human pancreatic islets to withstand ischemic injuries and promote immune evasion$686,375
R01 · FY2022 · DK · contact PI
Multiplex in situ gene expression and phenotypical profiling of inflamed tissues$386,875
U24 · FY2019 · AI
Core B Flow Cytometry & Cell Sorting$209,713
P30 · FY2019 · DK · contact PI
Donor-Alloantigen-Reactive Regulatory T Cell Therapy in Liver Transplantation$845,402
U01 · FY2018 · AI
Multiplex in situ gene expression and phenotypical profiling of inflamed tissues$391,595
U24 · FY2018 · AI
Core B Flow Cytometry & Cell Sorting$209,713
P30 · FY2018 · DK · contact PI
Donor-Alloantigen-Reactive Regulatory T Cell Therapy in Liver Transplantation$987,163
U01 · FY2017 · AI
Multiplex in situ gene expression and phenotypical profiling of inflamed tissues$391,598
U24 · FY2017 · AI
Core B Flow Cytometry & Cell Sorting$209,715
P30 · FY2017 · DK · contact PI
Donor-Alloantigen-Reactive Regulatory T Cell Therapy in Liver Transplantation$976,841
U01 · FY2016 · AI
Multiplex in situ gene expression and phenotypical profiling of inflamed tissues$397,467
U24 · FY2016 · AI
Core B Flow Cytometry & Cell Sorting$209,713
P30 · FY2016 · DK · contact PI
Donor-Alloantigen-Reactive Regulatory T Cell Therapy in Liver Transplantation$982,619
U01 · FY2015 · AI
Multiplex in situ gene expression and phenotypical profiling of inflamed tissues$400,000
U24 · FY2015 · AI
Core B Flow Cytometry & Cell Sorting$209,547
P30 · FY2015 · DK · contact PI
Donor-Alloantigen-Reactive Regulatory T Cell Therapy in Liver Transplantation$983,209
U01 · FY2014 · AI
"Regulatory 'T' Cell Control of Autoimmune Diabetes".$324,833
R01 · FY2014 · DK · contact PI
"Regulatory 'T' Cell Control of Autoimmune Diabetes".$314,152
R01 · FY2013 · DK · contact PI
"Donor-Specific Regulatory T Cell Therapy in Liver Transplantation"$57,242
R34 · FY2013 · AI
"Regulatory 'T' Cell Control of Autoimmune Diabetes".$326,194
R01 · FY2012 · DK · contact PI
"Donor-Specific Regulatory T Cell Therapy in Liver Transplantation"$246,373
R34 · FY2012 · AI
"Regulatory 'T' Cell Control of Autoimmune Diabetes".$326,783
R01 · FY2011 · DK · contact PI
BD FACS ARIA II CELL SORTER$495,100
S10 · FY2010 · RR · contact PI
"Regulatory 'T' Cell Control of Autoimmune Diabetes".$330,626
R01 · FY2010 · DK · contact PI
Cytometry and Cell Sorting$129,219
P30 · FY2010 · DK · contact PI
Visualizing regulatory T cell control of autoimmunity$184,925
R21 · FY2006 · AI · contact PI
Visualizing regulatory T cell control of autoimmunity$227,250
R21 · FY2005 · AI
T CELL ACTIVATION AND ANERGY INDUCTION BY ANTI-CD3$50,116
F32 · FY2002 · AI
T CELL ACTIVATION AND ANERGY INDUCTION BY ANTI-CD3$43,772
F32 · FY2001 · AI